|
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
||
|
|
|
|
||
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
|
Smaller reporting company
|
|
Emerging growth company
|
|
Page
|
||
|
PART 1 - FINANCIAL INFORMATION
|
||
|
Item 1.
|
||
| 1 | ||
| 2 | ||
| 3 | ||
| 5 | ||
| 6 | ||
|
Item 2.
|
25 | |
|
Item 3.
|
29 | |
|
Item 4.
|
29 | |
|
PART II - OTHER INFORMATION
|
||
|
Item 1.
|
30 | |
|
Item 1A.
|
30 | |
|
Item 2.
|
31 | |
|
Item 3.
|
31 | |
|
Item 4.
|
31 | |
|
Item 5.
|
31 |
|
|
Item 6.
|
32 | |
| 33 | ||
|
September 30, 2022
|
December 31, 2021
|
|||||||
|
(Unaudited)
|
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash
|
$
|
|
$
|
|
||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Investments held in Trust Account
|
|
|
||||||
|
Total Assets
|
$
|
|
$
|
|
||||
|
LIABILITIES, REDEEMABLE CLASS A COMMON STOCK AND STOCKHOLDERS’ DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$
|
|
$
|
|
||||
|
Franchise tax payable
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Warrant liabilities
|
|
|
||||||
|
Deferred underwriting fee payable
|
|
|
||||||
|
Total Liabilities
|
|
|
||||||
|
Commitments and Contingencies (Note 6)
|
||||||||
|
Class A common stock, $
|
|
|
||||||
|
Stockholders’ Deficit
|
||||||||
|
Preferred stock, $
|
|
|
||||||
|
Class A common stock, $
|
|
|
||||||
|
Class B common stock, $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total Stockholders’ Deficit
|
(
|
)
|
(
|
)
|
||||
|
TOTAL LIABILITIES, REDEEMABLE CLASS A COMMON STOCK AND STOCKHOLDERS’ DEFICIT
|
$
|
|
$
|
|
||||
|
For the Three Months Ended September 30, 2022
|
For the Three Months Ended September 30, 2021 | For the Nine Months Ended September 30, 2022 |
For the Period from March 1, 2021
(inception) Through September 30, 2021
|
|||||||||||||
|
Formation and operating costs
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||
| Franchise tax | ||||||||||||||||
| Loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Other income (expense) |
||||||||||||||||
|
Expensed offering costs
|
( |
) | ( |
) | ||||||||||||
|
Realized gain on investments held in Trust Account
|
||||||||||||||||
|
Unrealized gain on investments held in Trust Account
|
||||||||||||||||
|
Gain from change in fair value of warrant liabilities
|
||||||||||||||||
| Total other income, net |
||||||||||||||||
|
Net income
|
$
|
|
$ | $ |
$
|
|
||||||||||
|
Weighted average shares outstanding, Class A common stock subject to possible redemption
|
|
|
||||||||||||||
|
Basic and diluted net income per share, Class A common stock subject to possible redemption
|
$
|
|
$ | $ |
$
|
|
||||||||||
| Weighted average shares outstanding, Class B common stock(1) | ||||||||||||||||
| Basic and diluted net income (loss) per share, Class B common stock | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||
| For the Nine Months Ended September 30, 2022 | ||||||||||||||||||||||||||||
|
Class A Common Stock
|
Class B Common Stock
|
Additional |
Total
|
|||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Paid-in
Capital
|
Accumulated Deficit
|
Stockholders’
Deficit
|
||||||||||||||||||||||
|
Balance as of December 31, 2021
|
|
$
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||
|
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of March 31, 2022
|
—
|
|
—
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Net income
|
—
|
|
—
|
|
|
|
|
|||||||||||||||||||||
|
Balance as of March 31, 2022
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of June 30, 2022
|
— |
— |
( |
) | ( |
) | ||||||||||||||||||||||
|
Net income
|
—
|
|
—
|
|
|
|
|
|||||||||||||||||||||
|
Balance as of June 30, 2022
|
|
$
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||
|
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of September 30, 2022
|
— | — | ( |
) | ( |
) | ||||||||||||||||||||||
|
Net income
|
— | — | ||||||||||||||||||||||||||
|
Balance as of September 30, 2022
|
$ |
$ |
$ |
$ |
( |
) | $ |
( |
) | |||||||||||||||||||
| For the Period from March 1, 2021 (inception) Through September 30, 2021 | ||||||||||||||||||||||||||||
|
Class A Common Stock
|
Class B Common Stock
|
Additional |
Total
|
|||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Paid-in
Capital
|
Accumulated
Deficit |
Stockholders’
Equity (Deficit)
|
||||||||||||||||||||||
|
Balance as of March 1, 2021
(inception)
|
|
$
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
|
Issuance of Class B common stock to Sponsor(1)
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
—
|
|
—
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of March 31, 2021
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||
|
Net loss
|
—
|
|
—
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2021
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
|
Excess of cash received over the fair value of the private placement warrants
|
— | — | ||||||||||||||||||||||||||
|
Excess of fair value of Founder Shares sold over the purchase price
|
— | — | ||||||||||||||||||||||||||
|
Excess of cash received over the fair value of the over-allotment private placement warrants
|
— | — | ||||||||||||||||||||||||||
|
Forfeiture of Class B common stock
|
( |
) | ( |
) | ||||||||||||||||||||||||
|
Accretion of Class A common stock to redemption amount
|
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
| Net income | — | — | ||||||||||||||||||||||||||
|
Balance as of September 30, 2021
|
$ |
$ |
$ |
$ |
( |
) | $ |
( |
) | |||||||||||||||||||
|
For the Nine
Months Ended
September 30, 2022
|
For the Period from
March 1, 2021
(inception) Through
September 30, 2021
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
|
Realized gain on investments held in Trust Account
|
(
|
)
|
|
|||||
|
Unrealized gain on investments held in Trust Account
|
(
|
)
|
(
|
)
|
||||
|
Expensed offering costs
|
||||||||
|
Change in fair value of warrant liabilities
|
(
|
)
|
(
|
)
|
||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Prepaid expenses
|
|
(
|
)
|
|||||
|
Accounts payable and accrued expenses
|
(
|
)
|
|
|||||
|
Franchise tax payable
|
(
|
)
|
|
|||||
|
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
|
Cash Flows from Investing Activities:
|
||||||||
| Proceeds from redemption of U.S. government treasury obligations | ||||||||
|
Purchase of U.S. government treasury obligations
|
( |
) | ||||||
| Investment of cash into Trust Account | ( |
) | ||||||
|
Net cash used in investing activities
|
( |
) | ||||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Proceeds from promissory note - related party
|
|
|||||||
| Repayment of promissory note - related party | ( |
) | ||||||
| Proceeds from initial public offering, net of underwriting fees | ||||||||
| Proceeds from sale of Private Placement Warrants | ||||||||
|
Payment of deferred offering costs
|
|
(
|
)
|
|||||
|
Proceeds from sale of Class B common stock to Sponsor
|
|
|
||||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Net Change in Cash
|
(
|
)
|
|
|||||
|
Cash - Beginning of period
|
|
|
||||||
|
Cash - End of period
|
$
|
|
$
|
|
||||
|
Non-cash investing and financing activities
|
||||||||
| Deferred underwriting fee payable | $ | $ | ||||||
| Excess of the fair value of Founder Shares sold over the purchase price | $ | $ | ||||||
| Forfeiture of Class B common stock | $ | $ | ||||||
| Accretion of Class A common stock subject to redemption to redemption value | $ | $ | ||||||
|
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of September 30, 2022
|
$
|
|
$
|
|
||||
|
Deferred offering costs included in accrued offering costs
|
$
|
|
$
|
|
||||
|
Gross proceeds
|
$
|
|
||
|
Less:
|
||||
|
Proceeds allocated to Public Warrants
|
(
|
)
|
||
|
Issuance costs allocated to Class A common stock
|
(
|
)
|
||
|
Plus:
|
||||
|
Initial accretion of carrying value to redemption value
|
|
|||
|
Subsequent accretion of carrying value to redemption value as of December 31, 2021
|
|
|||
|
Class A common stock subject to possible redemption as of December 31, 2021
|
|
|||
|
Subsequent accretion of carrying value to redemption value as of March 31, 2022
|
|
|||
|
Class A common stock subject to possible redemption as of March 31, 2022
|
|
|||
|
Subsequent accretion of carrying value to redemption value as of June 30, 2022
|
||||
| Class A common stock subject to possible redemption as of June 30, 2022 | $ |
|||
|
Subsequent accretion of carrying value to redemption value as of September 30, 2022
|
||||
| Class A common stock subject to possible redemption as of September 30, 2022 | $ |
|
For the three months
ended September 30, 2022
|
For the three months
ended September 30, 2021
|
For the nine months
ended September 30, 2022
|
For the Period from
March 1, 2021
(inception) Through
September 30, 2021
|
|||||||||||||
|
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Less: Accretion of Class A common stock to redemption amount
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net income (loss) including accretion of temporary equity to redemption value
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
For the Three Months
Ended September 30, 2022
|
For the Three Months
Ended September 30, 2021
|
For the Nine Months
Ended September 30, 2022
|
For the Period from
March 1, 2021
(inception) Through
September 30, 2021
|
|||||||||||||||||||||||||||||
|
Class A
|
Class B
|
Class A
|
Class B
|
Class A
|
Class B
|
Class A
|
Class B
|
|||||||||||||||||||||||||
|
Basic and diluted net income per share:
|
||||||||||||||||||||||||||||||||
|
Numerator:
|
||||||||||||||||||||||||||||||||
|
Net income (loss) including accretion of temporary equity to redemption value
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||
|
Accretion of Class A common stock to redemption amount
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Net income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
||||||||||||||
|
Denominator:
|
||||||||||||||||||||||||||||||||
|
Weighted Average Common Stock
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Basic and diluted net income (loss) per common share
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
||||||||||||||
| • |
in whole and not in part;
|
| • |
at a price of $
|
| • |
upon not less than
|
| • |
if, and only if, the last reported sale price of the Class A common stock for any
|
| • |
in whole and not in part;
|
| • |
at $
|
| • |
if, and only if, the Reference Value equals or exceeds $
|
| • |
if the Reference Value is less than $
|
|
September 30, 2022
|
December 31, 2021
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Start-up costs
|
$
|
|
$
|
|
||||
|
Net operating loss carryforwards
|
|
|
||||||
|
Total deferred tax assets
|
|
|
||||||
|
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
|
Deferred tax liabilities:
|
||||||||
|
Unrealized gain on investments
|
(
|
)
|
(
|
)
|
||||
|
Total deferred tax liabilities
|
(
|
)
|
(
|
)
|
||||
|
Deferred tax assets, net of allowance
|
$
|
|
$
|
|
||||
|
Federal
|
||||
|
Current
|
$
|
|
||
|
Deferred
|
(
|
)
|
||
|
State
|
||||
|
Current
|
$
|
|
||
|
Deferred
|
|
|||
|
Change in valuation allowance
|
|
|||
|
Income tax provision
|
$
|
|
||
|
September 30, 2022
|
December 31, 2021
|
|||||||
|
Statutory federal income tax rate
|
|
%
|
|
%
|
||||
|
State taxes, net of federal tax benefit
|
|
%
|
|
%
|
||||
|
Change in fair value of derivative warrant liabilities
|
(
|
)%
|
(
|
)%
|
||||
|
Non-deductible transaction costs
|
|
% |
|
%
|
||||
|
Change in valuation allowance
|
( |
)% |
|
%
|
||||
|
Income tax provision
|
|
%
|
|
%
|
||||
|
Description
|
Amount at
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
September 30, 2022
|
||||||||||||||||
|
Assets
|
||||||||||||||||
|
Investments held in Trust Account:
|
||||||||||||||||
|
U.S. government treasury obligations
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Liabilities
|
||||||||||||||||
|
Warrant liability – Public Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Warrant liability – Private Placement Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Description
|
Amount at
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
December 31, 2021
|
||||||||||||||||
|
Assets
|
||||||||||||||||
|
Investments held in Trust Account:
|
||||||||||||||||
|
U.S. government treasury obligations
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Liabilities
|
||||||||||||||||
|
Warrant liability – Public Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Warrant liability – Private Placement Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
As of July 30,
2021 (Initial
Measurement)
|
||||
|
Stock price
|
$
|
|
||
|
Exercise price
|
$
|
|
||
|
Dividend yield
|
|
% |
||
|
Expected term (in years)
|
|
|||
|
Volatility
|
|
%
|
||
|
Risk-free rate
|
|
%
|
||
|
Fair value
|
$
|
|
||
|
Fair value as of March 1, 2021
|
$
|
|
||
|
Initial measurement of Public Warrants and Private Placement Warrants as of July 30, 2021
|
|
|||
|
Initial measurement of Public Warrants and Private Placement Warrants upon exercise of over-allotment on August 20, 2021
|
|
|||
|
Transfer of Public Warrants to Level 1 measurement
|
(
|
)
|
||
|
Transfer of Private Placement Warrants to Level 2 measurement
|
(
|
)
|
||
|
Change in fair value
|
(
|
)
|
||
|
Fair value as of December 31, 2021
|
$
|
|
||
|
Change in fair value
|
|
|||
|
Fair value as of March 31, 2022
|
$
|
|
||
| Change in fair value | ||||
| Fair value as of June 30, 2022 | $ | |||
| Change in fair value |
||||
| Fair value as of September 30, 2022 |
$ |
|
As of July 30, 2021
(Initial
Measurement)
|
||||
|
Stock price
|
$
|
9.47
|
||
|
Exercise price
|
$
|
11.50
|
||
|
Dividend yield
|
—
|
%
|
||
|
Expected term (in years)
|
5.5
|
|||
|
Volatility
|
20.0
|
%
|
||
|
Risk-free rate
|
0.80
|
%
|
||
|
Fair value
|
$
|
0.95
|
||
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk.
|
| ITEM 1. |
LEGAL PROCEEDINGS
|
| ITEM 1A. |
RISK FACTORS
|
| ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
| ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES
|
| ITEM 4. |
MINE SAFETY DISCLOSURES
|
| ITEM 5. |
OTHER INFORMATION
|
| ITEM 6. |
EXHIBITS
|
|
Exhibit No.
|
Description
|
|
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101.INS*
|
XBRL Instance Document
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
*
|
Filed herewith.
|
|
**
|
Furnished.
|
|
Mercury Ecommerce Acquisition Corp.
|
||
|
Date: November 10, 2022
|
By:
|
/s/ Andrew White
|
|
Name: Andrew White
|
||
|
Title: Chief Executive Officer
|
||
|
Mercury Ecommerce Acquisition Corp.
|
||
|
Date: November 10, 2022
|
By:
|
/s/ Winston Gilpin
|
|
Name: Winston Gilpin
|
||
|
Title: Chief Financial Officer
|
||